PKM2 is overexpressed in thyroid cancer cell lines of TPC1, K1 and BCPAP, which is due to aberrant down-regulation of the tumor suppressive miRNAs, miR-148a and miR-326 [42,52]. Here, PKM is linked to thyroid gland carcinoma.